| RAPid SimPLE Targeted Radiation Treatment for Brain Metastases (NCT05050929) | British Columbia Cancer Agency | 2022-07-01 |
| A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain (NCT05419076) | Memorial Sloan Kettering Cancer Center | 2022-06-10 |
| Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery (NCT04689048) | Baptist Health South Florida | 2022-04-04 |
| Managing Distress in Malignant Brain Cancer (NCT05087095) | Virginia Commonwealth University | 2022-03-23 |
| Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases (NCT04711824) | Colette Shen | 2022-03-09 |
| Survivorship Study of Cancer Patients Who Received Cranial Radiation Therapy (NCT04567251) | Duke University | 2021-12-28 |
| Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases (NCT05012254) | Fundación GECP | 2021-11-18 |
| Brain Imaging Biomarkers in Patients With Brain Metastasis (NCT04197297) | University Health Network, Toronto | 2021-10-05 |
| Stereotactic Radiosurgery vs Whole Brain Radiotherapy in Breast Cancer With Brain Oligometastasis (NCT05144867) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2021-08-31 |
| Exploring Compensation to Maintain Cognitive Function in Adults Newly Diagnosed With Brain Cancer (NCT04075370) | Duke University | 2021-07-22 |
| Re-TREAT: Re-irradiation for Relapsed Brain Metastases (NCT05126875) | Rigshospitalet, Denmark | 2021-07-01 |
| Accelerated Checkpoint Therapy for Any Steroid Dependent Patient With Brain Metastases (NCT04461418) | AHS Cancer Control Alberta | 2021-03-30 |
| A Neurocognitive Study in Patients With Brain Oligometastases Receiving Hypofractionated SRT (NCT04805255) | Chang Gung Memorial Hospital | 2021-02-25 |
| Safety Study of Pritumumab in Brain Cancer (NCT04396717) | Nascent Biotech | 2021-02-22 |
| Multi -paramEtric Imaging to Assess Treatment REsponse After Stereotactic Radiosurgery of Brain Metastases (NCT04626206) | Royal Marsden NHS Foundation Trust | 2020-12-01 |
| Neoadjuvant Immunotherapy in Brain Metastases (NCT04434560) | Sarah Sammons, MD | 2020-11-04 |
| Local Ablative Therapy for Patients With Multiple (4-10) Brain Metastases (NCT04397978) | Universitaire Ziekenhuizen KU Leuven | 2020-10-10 |
| LITT and Pembrolizumab in Recurrent Brain Metastasis (NCT04187872) | University of Florida | 2020-01-10 |
| Focal Intraoperative Radiotherapy of Brain Metastases (NCT03789149) | AC Camargo Cancer Center | 2019-05-02 |
| UCSD Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases (NCT04343157) | Jona Hattangadi-Gluth | 2019-05-01 |
| The Cohort for Patient-reported Outcomes, Imaging and Trial Inclusion in Metastatic BRAin Disease (COIMBRA) (NCT05267158) | UMC Utrecht | 2019-04-26 |
| Radiotherapy of Multiple Brain Metastases Using AGuIX® (NCT03818386) | University Hospital, Grenoble | 2019-03-26 |
| Revision of the EORTC QLQ-BN20 Questionnaire (NCT04689321) | Leiden University Medical Center | 2018-12-19 |
| Stereotactic Radiotherapy of the Resection Cavity of Brain Metastases vs. Post-operative Whole-brain Radiotherapy (NCT03285932) | Juergen Debus | 2018-02-01 |
| Comparaison Between MRI Alone or Combined With Positron Emission Tomography for Brain Metastasis Diagnosis (NCT05095766) | Centre de recherche du Centre hospitalier universitaire de Sherbrooke | 2017-11-23 |
| Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases (NCT02978404) | Centre hospitalier de l'Université de Montréal (CHUM) | 2017-06-02 |
| SIMT Stereotactic Radiosurgery Outcomes Study (NCT02886572) | Duke University | 2017-01-25 |
| Hypofractionated Brain Radiationcavity (NCT03561896) | Oncology Institute of Southern Switzerland | 2015-01-01 |
| Intrafractional Head Movement During Radiosurgery (NCT03896555) | Medical University Innsbruck | 2014-11-01 |